FDA Archives - tgiHealthCareerp

FDA Approves Keytruda (pembrolizumab) Plus Lenvima (lenvatinib) Combination for Patients With Certain Types of Advanced Endometrial Carcinoma

07/26/2021 (pembrol, Approves, FDA, Keytruda

KENILWORTH & WOODCLIFF, N.J.–(BUSINESS WIRE) July 22, 2021 — Merck (NYSE: MRK), known as MSD outside the United States and

Medications

FDA Approves Rezurock

07/22/2021 Approves, FDA, Rezurock

FDA Approves Rezurock (belumosudil) for the Treatment of Patients with Chronic Graft-Versus-Host Disease (cGVHD) NEW YORK, NY / ACCESSWIRE /

Medications

FDA Approves Rylaze

07/02/2021 Approves, FDA, Rylaze

FDA Approves Rylaze for the Treatment of Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma DUBLIN, June 30, 2021 /PRNewswire/ — Jazz

Health News

FDA approval of Biogen's Alzheimer's drug leaves some 'disappointed'

06/08/2021 Approval, Biogen's, FDA, of

Fox News Flash top headlines for June 8 Fox News Flash top headlines are here. Check out what’s clicking on

Medications

FDA Approves Merck’s Keytruda (pembrolizumab) Combined With Trastuzumab and Chemotherapy as First-line Treatment in Locally Advanced Unresectable or Metastatic HER2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma

05/11/2021 Approves, FDA, Keytruda, Merck’s

KENILWORTH, N.J.–(BUSINESS WIRE) May 5, 2021– Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced

Medications

FDA Approves Opdivo (nivolumab) in Combination with Chemotherapy for Patients with Advanced or Metastatic Gastric Cancer, Gastroesophageal Junction Cancer, and Esophageal Adenocarcinoma Regardless of PD-L1 Expression Status

04/18/2021 (nivolumab), Adenocarcinoma, advanced, and, Approves, cancer, chemotherapy, Combination, Esophageal, expression, FDA, for, gastric, gastroesophageal, in, Junction, metastatic, of, Opdivo, or, Patients, PD-L1, regardless, status, with

PRINCETON, N.J.–(BUSINESS WIRE)– April 16, 2021 Opdivo is the first and only immunotherapy in combination with chemotherapy to deliver superior overall

Health News

Serious, ‘Unexpected’ Adverse Events From Nasal Esketamine

04/16/2021 affective disorders, anxiety disorder, benzodiazepines, Depression, Europe, European, FDA, Mood Disorder, panic attack, psychophysiologic disorder, psychophysiologic illness, psychosomatic, psychosomatic disorder, psychosomatic illness, Psychotherapy, sedation, Suicide, U.S. Food and Drug Administration, united states food and drug administration

Patients who receive esketamine for treatment-resistant depression (TRD) are at increased risk for serious and unexpected adverse events (AEs), new

Health News

US Government Directs Johnson & Johnson to Run Vaccine Plant

04/05/2021 2019 Novel Coronavirus, 2019-nCoV, coronavirus, coronavirus vaccine, covid 19 vaccine, FDA, HCoV-229E, HCoV-OC43, Human coronavirus 229E, Human coronavirus HKU1, Human coronavirus OC43, leadership, pandemic, professional development, quality control, U.S. Food and Drug Administration, united states food and drug administration, vaccine, wuhan coronavirus

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Federal health officials on Saturday put

Health News

US Plans to Use Real World, Trial Data to Determine When Vaccines Need to Be Updated

03/18/2021 2019 Novel Coronavirus, 2019-nCoV, clinical research, clinical studies, clinical trials, Corona Virus, coronavirus vaccine, covid 19, covid 19 vaccine, covid19, FDA, HCoV-229E, HCoV-OC43, Human coronavirus 229E, Human coronavirus HKU1, Human coronavirus OC43, novel coronavirus, U.S. Food and Drug Administration, united states food and drug administration, vaccine, Vaccines, wuhan coronavirus

CHICAGO (Reuters) – U.S. officials plan to use data gathered from people who have already been vaccinated against COVID-19 as

Health News

Insider Alleges Eli Lilly Blocked Her Efforts to Sound Alarms About US Drug Factory

03/12/2021 diabetes mellitus type 2, diabetes mellitus type ii, drug safety, drug/treatment safety, ED, Erectile Dysfunction, Ethics, FDA, headache (migraine), Impotence, Migraine, migraine headache, patient safety, quality control, treatment safety, Type 2 Diabetes, U.S. Food and Drug Administration, united states food and drug administration

(Reuters) – On a chilly spring morning in 2019, Amrit Mula arrived in her office at pharmaceutical giant Eli Lilly

← Previous